Home > Drug Search >
  • company_query: Beijing Bio-Fortune
  •   > 
Drug Filter
Category:
chemistry (2) biology (44)
Status:
Approved (7) BLA Filing (1) Phase Ⅲ (14) Phase Ⅱ (11) Phase Ⅰ (12)
Clinical Stage:
Pending (1) Active (36) Discontinued (2)
Bio-Type:
Coagulation factor (1) Gene therapy (1) CAR T cell therapy (4) Vaccine (14) Recombinant polypeptide (1) Other recombinant protein (1) Whole antibody (13) ADC (1) Fusion protein (3)
Indication:
Meningitis (2) Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (1) Atherosclerosis (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Cholera (1) Transplant rejection (1) Penile cancer (1) Follicular lymphoma (1) HBV infection (3) HCV infection (1) Hepatocellular carcinoma (HCC) (1) Influenza virus infection (2) Hepatitis A viral infection (2) Rabies (1) Afibrinogenaemia (1) Leukemia (1) Melanoma (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Neuropathic pain (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (2) Ovarian cancer (1) Pancreatic cancer (1) Pneumonia (2) Diphtheria (1) Haemophilus infection (1) Pertussis (1) Prostate cancer (3) Tetanus (2) Rheumatoid arthritis (RA) (3) Solid tumours (1) Thyroid cancer (1) Colorectal cancer (3) Rejection of renal transplantation (1) Ankylosing Spondylitis (AS) (1) Neuroblastoma (2) Cervical carcinoma (1) Hemophilia A (1) Neutropenia (1) Renal carcinoma (1) Autoimmune diseases (1) Pressure sore (1) Glioblastoma (2) Glioma (1) Plaque psoriasis (1) Allergic asthma (1) Diffuse large B cell lymphoma (3) Inflammation (1) Human papillomavirus infections (HPV) (2)
Country:
Aprv. Year:
 (2) 2012 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top